Blood pressure monitors are used to measure blood pressure of patients in hospitals, who are critically ill or are going to be operated of any surgical procedure. Blood pressure monitors are present in operating room, intensive care units, surgical recovery rooms, emergency departments and other critical care areas for frequent or continuous measurement of blood pressure. During critical conditions of patient, it is necessary to check blood pressure which plays an important role in diagnosis. Whereas, blood pressure measurement is integral to intensive care units to check vital signs and is also used to screen for hypertension, to estimate cardiovascular risk and manage, diagnose and treat acute and chronic medical conditions.
Furthermore, noninvasive blood pressure method is highly adopted, the most popular non-invasive techniques used are sphygmomanometer and auscultation. The non-invasive blood pressure monitor mostly used in intensive critical unit is sphygmomanometer. As non-invasive blood pressure monitor are simpler and quicker than the invasive measurements and also requires less expertise in fitting and have no virtual complications and are also less painful for patient this expected to favor the growth of non-invasive blood pressure monitor market in the near future. However, non-invasive blood pressure monitor are somewhat less accurate and also shows little systematic differences in numerical results, however, are most often used for routine checkup.
Non-invasive Blood Pressure Monitors Market Taxonomy
By Device Type
By End User
Rise in number of cardiovascular diseases expected to fuel the growth of non-invasive blood pressure monitors market
The risk of cardiovascular disease increase above 115/75 mmHg. In the UK, blood pressure is classified into 3 groups; low (90/60 or lower), normal (between 90/60 and 139/89), and high (140/90 or higher). Blood pressure fluctuates from minute to minute and show a circadian rhythm within 24 hours. In the U.S. leading cause of death are heart disease and stroke due to high blood pressure. According to Centers for Disease Control and Prevention, in year 2016, about 75 million adults of the U.S. had high blood pressure which is expected to support the growth of non-invasive blood pressure monitors market. Low blood pressure also favors the market of non-invasive blood pressure monitors as it is associated with serious symptoms such as, dizziness, nausea, fatigue, cold, pale skin or blurred vision.
Regional growth engines for the non-invasive blood pressure monitors market
On the basis of regional segmentation, the global colostomy bags market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The emerging economics such as India, China, Brazil, and South Africa are expected to be major target geographies for market players. North America is expected to show growth in market due to its continuous growth in aging population and rate of disease related to high blood pressure. As according to Population Reference Bureau, the number of people of the U.S. aged over 65 years is projected to more than double from 46 million in 2016 to 98 million by 2060. Furthermore decline in price to make noninvasive blood pressure monitors cost effective for hospitals expected to favor the noninvasive blood pressure monitors market in Asia Pacific region.
Key players dominating in the non-invasive blood pressure monitors market
Non-invasive blood pressure monitor providers in the market are trying to offer broad and cost- effective range of non-invasive blood pressure monitors in the market by using advanced technology and innovation in products, which in turn is increasing competitive rivalry. In May 2017, Deltex Medical was granted patent for combined blood flow and blood pressure monitor by non-invasive method which will favor the growth of market. Other key players operating in the market are GE healthcare, SOMNOmedics, Eccosur SA, Koninklijke Philips N.V., Huntleigh Technology Ltd, Mortara Instrument, Schiller Americans Inc, American Diagnostic Corporation and Welch Allyn.